Mark Sader

1.0k total citations
17 papers, 635 citations indexed

About

Mark Sader is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Sader has authored 17 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Sader's work include Hormonal and reproductive studies (5 papers), Menopause: Health Impacts and Treatments (5 papers) and Cardiovascular and Diving-Related Complications (4 papers). Mark Sader is often cited by papers focused on Hormonal and reproductive studies (5 papers), Menopause: Health Impacts and Treatments (5 papers) and Cardiovascular and Diving-Related Complications (4 papers). Mark Sader collaborates with scholars based in Australia, India and United States. Mark Sader's co-authors include David J. Handelsman, David S. Celermajer, Kaye A. Griffiths, Robyn J. McCredie, Kristine McGrath, Alison K. Death, David S Celermajer, Wendy Jessup, Shirley Nakhla and Michael R. Skilton and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Endocrinology.

In The Last Decade

Mark Sader

16 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Sader Australia 8 325 192 110 80 73 17 635
Maro R. I. Williams Australia 10 407 1.3× 271 1.4× 187 1.7× 105 1.3× 99 1.4× 11 772
Bruce H. Pinkernell United States 7 420 1.3× 176 0.9× 120 1.1× 88 1.1× 50 0.7× 11 630
Béla Székács Hungary 13 265 0.8× 114 0.6× 173 1.6× 64 0.8× 124 1.7× 62 626
Sabin Allemann Switzerland 13 585 1.8× 185 1.0× 100 0.9× 144 1.8× 137 1.9× 16 852
Abdullah Taşlıpınar Türkiye 15 320 1.0× 83 0.4× 47 0.4× 224 2.8× 63 0.9× 47 800
Ling Ge United States 11 483 1.5× 190 1.0× 73 0.7× 192 2.4× 66 0.9× 24 798
Masahiko Furuta Japan 9 204 0.6× 132 0.7× 52 0.5× 130 1.6× 186 2.5× 15 660
Sônia Alves Gouvêa Brazil 16 147 0.5× 156 0.8× 87 0.8× 96 1.2× 149 2.0× 45 707
L. Bordier France 12 265 0.8× 84 0.4× 51 0.5× 107 1.3× 149 2.0× 95 666
Rika Araki-Sasaki Japan 11 286 0.9× 120 0.6× 51 0.5× 180 2.3× 253 3.5× 11 788

Countries citing papers authored by Mark Sader

Since Specialization
Citations

This map shows the geographic impact of Mark Sader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sader more than expected).

Fields of papers citing papers by Mark Sader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sader. The network helps show where Mark Sader may publish in the future.

Co-authorship network of co-authors of Mark Sader

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sader. A scholar is included among the top collaborators of Mark Sader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sader. Mark Sader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Youssef, George, et al.. (2021). Carcinoid heart disease of gonadal primary presenting with hypoxia: a case report. European Heart Journal - Case Reports. 5(5). ytaa536–ytaa536. 2 indexed citations
2.
Youssef, George, et al.. (2021). Recurrent stroke secondary to late patent foramen ovale-closure device thrombus: a case report. European Heart Journal - Case Reports. 5(8). ytab313–ytab313. 1 indexed citations
3.
Hopkins, A., et al.. (2021). Cost-Effectiveness and Safety of Same-Day Discharge after Elective Percutaneous Coronary Intervention. SHILAP Revista de lepidopterología. 2(4). 561–569. 2 indexed citations
4.
Sader, Mark, et al.. (2021). Safety and Cost Implications of Same-Day Discharge Following Elective Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defects in Australia. SHILAP Revista de lepidopterología. 2(4). 543–550. 3 indexed citations
5.
Sader, Mark, et al.. (2021). Multimodal Imaging and Endomyocardial Biopsy in the Assessment and Diagnosis of a Cardiac Melanoma. Circulation Cardiovascular Imaging. 14(9). e012953–e012953. 1 indexed citations
6.
Ford, Thomas J., Alice G. Cheng, George Youssef, Mark Sader, & David Rees. (2016). PS164 Underdosing of Noacs for AF: Old Habits Die Hard. Global Heart. 11(2). e41–e41. 1 indexed citations
7.
Weaver, James B., et al.. (2015). Removing the Antiscatter Grid: A simple way to lower radiation during both Angiography and PCI. Heart Lung and Circulation. 24. S298–S298. 1 indexed citations
8.
Sader, Mark, et al.. (2012). Dynamic echocardiography in evaluation of platypnoea‐orthodeoxia. Australasian Journal of Ultrasound in Medicine. 15(2). 71–75.
9.
Sader, Mark, Kristine McGrath, Ken Bradstock, et al.. (2004). Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis. Clinical Endocrinology. 62(1). 56–63. 45 indexed citations
10.
Griffiths, Kaye A., Mark Sader, Michael R. Skilton, Jason A. Harmer, & David S. Celermajer. (2003). Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease. Journal of the American College of Cardiology. 42(4). 698–704. 37 indexed citations
11.
Sader, Mark, Kaye A. Griffiths, Michael R. Skilton, et al.. (2003). Physiological testosterone replacement and arterial endothelial function in men. Clinical Endocrinology. 59(1). 62–67. 51 indexed citations
12.
Sader, Mark, Michael de Moor, Eugene Pomerantsev, & Igor F. Palacios. (2003). Percutaneous transcatheter patent foramen ovale closure using the right internal jugular venous approach. Catheterization and Cardiovascular Interventions. 60(4). 536–539. 12 indexed citations
13.
Death, Alison K., Kristine McGrath, Mark Sader, et al.. (2003). Dihydrotestosterone Promotes Vascular Cell Adhesion Molecule-1 Expression in Male Human Endothelial Cells via a Nuclear Factor-κB-Dependent Pathway. Endocrinology. 145(4). 1889–1897. 127 indexed citations
14.
Sader, Mark, Laurie A. Miller, Diana Caine, et al.. (2002). Neuropsychological and psychiatric outcomes following coronary surgery or angioplasty: A comparative study. Heart Lung and Circulation. 11(2). 95–101. 5 indexed citations
15.
Sader, Mark. (2002). Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovascular Research. 53(3). 597–604. 212 indexed citations
16.
Sader, Mark, Kaye A. Griffiths, Robyn J. McCredie, David J. Handelsman, & David S Celermajer. (2001). Androgenic anabolic steroids and arterial structure and function in male bodybuilders. Journal of the American College of Cardiology. 37(1). 224–230. 101 indexed citations
17.
Sader, Mark, Robyn J. McCredie, Kaye A. Griffiths, et al.. (2001). Oestradiol improves arterial endothelial function in healthy men receiving testosterone. Clinical Endocrinology. 54(2). 175–181. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maro R. I. Williams Breakdown of academic impact, for papers by Bruce H. Pinkernell Breakdown of academic impact, for papers by Béla Székács Breakdown of academic impact, for papers by Sabin Allemann Breakdown of academic impact, for papers by Abdullah Taşlıpınar Breakdown of academic impact, for papers by Ling Ge Breakdown of academic impact, for papers by Masahiko Furuta Breakdown of academic impact, for papers by Sônia Alves Gouvêa Breakdown of academic impact, for papers by L. Bordier Breakdown of academic impact, for papers by Rika Araki-Sasaki
Rankless by CCL
2026